![](https://endpts.com/wp-content/uploads/2023/06/John-Mendlein-Sabrina-Yang-Jason-Park-Doug-Cole-Empress-tile1.jpg)
Empress Therapeutics co-founders from L-R: John Mendlein, Sabrina Yang, Jason Park, and Doug Cole.
Flagship startup Empress Therapeutics launches to search for small molecule drug leads in microbial DNA
Flagship’s latest startup is betting that a treasure trove of small molecule drugs is waiting to be discovered right inside our bodies — or rather, inside …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.